Atreca
Ms. Ball is the CEO of Soteria Biotherapeutics, Inc., a privately-held biotechnology company focused on immune-oncology. Before joining Soteria in 2020, she served as SVP of Corporate Strategy and CFO of Menlo Therapeutics, Inc., from 2017-2020 and as SVP and CFO of Relypsa, Inc., prior to the company’s acquisition by Galenica.
This person is not in the org chart
This person is not in any teams
This person is not in any offices